Curcumin-loaded nanoparticles reduce α-synuclein aggregation and mitochondrial dysfunction in Parkinson’s Disease ex vivo and in vitro models
Fields of Study & Subjects
Parkinson's Disease Mechanisms and Treatments
Curcumin's Biomedical Applications
Nanoparticle-Based Drug Delivery
Publication details
- Journal / source
- SSRN Electronic Journal
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Preprint